PharmaCielo Ltd. (PCLO.V)
CAD 0.09
(-10.0%)
CAD 0.09
(-10.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 8.33 Million CAD | -32.05% |
| 2022 | 12.26 Million CAD | -41.29% |
| 2021 | 20.88 Million CAD | -42.97% |
| 2020 | 36.61 Million CAD | 12.09% |
| 2019 | 32.67 Million CAD | 27445.49% |
| 2018 | 118.6 Thousand CAD | 642.12% |
| 2017 | 15.98 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.9 Million CAD | 52.68% |
| 2024 Q1 | 1.24 Million CAD | -4.09% |
| 2023 Q4 | 1.3 Million CAD | -34.35% |
| 2023 Q2 | 2.42 Million CAD | -16.31% |
| 2023 FY | 8.33 Million CAD | -32.05% |
| 2023 Q3 | 1.98 Million CAD | -18.34% |
| 2023 Q1 | 2.9 Million CAD | 62.91% |
| 2022 Q2 | 3.78 Million CAD | 14.88% |
| 2022 Q4 | 1.78 Million CAD | -47.83% |
| 2022 FY | 12.26 Million CAD | -41.29% |
| 2022 Q1 | 3.29 Million CAD | 7.86% |
| 2022 Q3 | 3.41 Million CAD | -9.73% |
| 2021 Q1 | 6.03 Million CAD | -60.65% |
| 2021 FY | 20.88 Million CAD | -42.97% |
| 2021 Q4 | 3.05 Million CAD | -54.99% |
| 2021 Q3 | 6.77 Million CAD | 20.98% |
| 2021 Q2 | 5.6 Million CAD | -7.14% |
| 2020 Q4 | 15.33 Million CAD | 149.91% |
| 2020 Q3 | 6.13 Million CAD | -21.82% |
| 2020 Q1 | 6.77 Million CAD | -16.82% |
| 2020 Q2 | 7.84 Million CAD | 15.77% |
| 2020 FY | 36.61 Million CAD | 12.09% |
| 2019 Q1 | 7.19 Million CAD | 68266.69% |
| 2019 FY | 32.67 Million CAD | 27445.49% |
| 2019 Q4 | 8.15 Million CAD | 30.48% |
| 2019 Q3 | 6.24 Million CAD | 98.14% |
| 2019 Q2 | 3.15 Million CAD | -56.19% |
| 2018 Q3 | 37.11 Thousand CAD | 34.89% |
| 2018 FY | 118.6 Thousand CAD | 642.12% |
| 2018 Q1 | 44.08 Thousand CAD | 345.97% |
| 2018 Q2 | 27.51 Thousand CAD | -37.59% |
| 2018 Q4 | 10.52 Thousand CAD | -71.64% |
| 2017 FY | 15.98 Thousand CAD | 0.0% |
| 2017 Q4 | 9886.00 CAD | -38.14% |
| 2017 Q3 | 15.98 Thousand CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 2.96 Million CAD | -181.115% |
| CanadaBis Capital Inc. | 7.1 Million CAD | -17.241% |
| Decibel Cannabis Company Inc. | 40.44 Million CAD | 79.4% |
| Delivra Health Brands Inc. | 7.1 Million CAD | -17.205% |
| Entourage Health Corp. | 3.7 Million CAD | -124.724% |
| Lifeist Wellness Inc. | 17.59 Million CAD | 52.643% |
| Cannara Biotech Inc. | 15.34 Million CAD | 45.694% |
| Medicure Inc. | 13.98 Million CAD | 40.438% |
| Rubicon Organics Inc. | 14.22 Million CAD | 41.423% |
| BioSyent Inc. | 17.6 Million CAD | 52.681% |
| Voyageur Pharmaceuticals Ltd. | 1.22 Million CAD | -582.427% |